Treatment of Porphyria cutanea tarda with Oral Thalidomide

Alexandra Monastirli,Sophia Georgiou,Klaus Bolsen,Efstathia Pasmatzi,A. Papapanagiotou,G. Goerz,A. Kalofoutis,Hans F. Merk,D. Tsambaos

Treatment of Porphyria cutanea tarda with Oral Thalidomide

1999

Alexandra Monastirli
Sophia Georgiou
Klaus Bolsen
Efstathia Pasmatzi
A. Papapanagiotou
G. Goerz
A. Kalofoutis
Hans F. Merk
D. Tsambaos

Eight male patients with overt clinical and biochemical features of porphyria cutanea tarda (PCT) were orally treated with 300 mg/day thalidomide for 1 week and with 200 mg/day for 3 more weeks. Alrea

Keywords:

Uroporphyrinogen III decarboxylase
Photosensitivity
Porphyria cutanea tarda
Thalidomide
Peripheral neuropathy
Endocrinology
Medicine
Diabetes mellitus
Chemotherapy
Internal medicine
Porphyria
Dermatology
male patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations